Abeona Therapeutics Inc. Quarterly report pursuant to Section 13 or 15(d)

OPERATING LEASES (Tables)

3 Months Ended

Mar. 31, 2019

Components of lease cost are as follows:

The following table presents information about the amount and timing of cash flows arising from operating leases as of March 31, 2019:

Maturity of lease liabilities:
2019, remainder	$	1,266,000
2020		1,699,000
2021		1,713,000
2022		1,727,000
2023		1,741,000
Thereafter		3,667,000
Total undiscounted operating lease payments		11,813,000
Less: imputed interest		3,196,000
Present value of operating lease liabilities	$	8,617,000

Balance sheet classification:
Current portion of lease liability	$	1,690,000
Long-term lease liability		6,927,000
Total operating lease liabilities	$	8,617,000

Other information:
Weighted-average remaining lease term for operating leases		82 months
Weighted-average discount rate for operating leases		9.6	%